Our people
What we do
Industries Practices Legal Tech

Aerospace and Defense

Automotive and Mobility

Consumer

Education

Energy and Natural Resources

Financial Institutions

Insurance

Life Sciences and Health Care

Manufacturing and Industrials

Mobility and Transportation

Private Capital

Real Estate

Sports, Media and Entertainment

Technology and Telecoms

Transportation and Logistics

Corporate & Finance

Disputes

Intellectual Property, Media, and Technology

Regulatory
Case studies
Our thinking
ESG
Join us

Search

Search

Deutsch
English
Español
Français
中文
日本語

About us
Where we are
Media center
Events and webinars
Responsible Business
Alumni

Knowledge

Across topics and issues, borders and industries, we have the thought leadership you need to stay ahead of changes in the law.

Follow us:

Resources

Supply Chains

Access our latest insights into supply chain risk management and governance.

Distressed Banks

Navigate the legal implications relating to banks in distress with our resource center.

Premium services

Click here to learn more about our range of premium tools

Comparative guides

View the global picture with our interactive comparative guides

Publications

Search

No results found

2

Filter by type

Insights and Analysis
News

Consumer
Energy and Natural Resources
Financial Institutions
Life Sciences and Health Care
Private Capital
Sports, Media and Entertainment
Technology and Telecoms

Antitrust and Competition
Capital Markets
Communications, Internet, and Media
Copyright
Corporate Governance and Public Company Representation
Digital Assets and Blockchain
Environment and Natural Resources
Financial Services
Food Law
Government Contracts
Government Relations and Public Affairs
Health
Infrastructure, Energy, Resources, and Projects
Intellectual Property
International Trade and Investment
International Trade Commission Section 337
Investigations, White Collar, and Fraud
IP and Technology Transactions
Joint Ventures
Medical Device and Technology Regulatory
Mergers and Acquisitions
Patents
Pharmaceuticals and Biotechnology Regulatory
Privacy and Cybersecurity
Private Equity
Securities and Public Company Advisory
Sovereigns
Strategic Operations, Agreements and Regulation
Trade Secrets and Confidential Know-how
Venture Capital and Emerging Companies

Data Centers
Distressed Banks
Environmental, Social, and Governance (ESG)
Eye on DC: Legislative and Regulatory Developments from the U.S. Capitol
Regulatory, Compliance & Investigation Solutions

2024
2023
2022
2021

Amsterdam
Beijing
Berlin
Boston
Brussels
Dublin
Dusseldorf
Hamburg
Jakarta
London
Los Angeles
Madrid
Milan
Munich
New York
Northern Virginia
Paris
São Paulo
Singapore
Sydney
Tokyo
Washington, D.C.

Insights and Analysis

Reverse DMA: The role of private enforcement

18 April 2024

The Digital Markets Act provides not only compliance duties, but also opportunities for those seeking to enforce their rights under the DMA. Be it enhancing interoperability or opening up...

News

FTC continues to highlight FDA Orange Book patent listings

05 April 2024

With the recent filing of an amicus brief in a private pharmaceutical patent infringement case, the Federal Trade Commission (FTC) has continued its focus on allegedly “improperly...

News

Commission investigation into termination of pipeline drug: what next for R&D decision-making?

02 April 2024

The European Commission has opened a formal investigation into whether Zoetis, a US animal health company, has acted in breach of the abuse of dominance rules by terminating development of...

News

Private equity investment in health care remains in U.S. antitrust enforcers’ crosshairs

13 March 2024

Private equity investment in the health care sector continues to be a significant area of focus for the U.S. antitrust agencies. On March 5, 2024, the Federal Trade Commission (FTC)...

News

Discover Your Boundaries – The European Commission's revised Market Definition Notice

13 February 2024

The European Commission (“Commission”) has unveiled its eagerly anticipated revision of the Market Definition Notice (the “Notice”), a landmark event since its...

News

FTC focused on competition and dominance in generative AI space

05 February 2024

On January 25, 2024 the Federal Trade Commission (FTC) hosted a Technology Summit focused on generative artificial intelligence (AI) and other innovative technologies to address how control ...

News

The European Commission report on competition enforcement in the pharmaceutical sector

01 February 2024

On 26 January 2024, the European Commission published a report on competition enforcement in the pharmaceutical sector, highlighting the role of EU competition law in safeguarding market...

News

HL Noodles

31 January 2024

We are pleased to introduce HL Noodles, our new monthly series focusing on concise and pithy thought pieces at the intersection of antitrust, philosophy, and economics. Please join us ...

News

Sport Meets Antitrust: Shaping the field of play – the CJEU weighs in on sports and antitrust

09 January 2024

Just before Christmas, the Court of Justice of the European Union (CJEU) delivered three eagerly awaited rulings that greatly affect the relationship between antitrust law and the autonomy...

Load more

Stay in the know Subscribe

Connect with us

Quick Links

Our people
Case studies
Our thinking

Responsible Business
Diversity, Equity & Inclusion

About us
Join us
Contact us

Cookies
Disclaimer
Legal notices
Modern Slavery Statement
Privacy
RSS

© 2024 Hogan Lovells. All rights reserved. "Hogan Lovells" or the “firm” refers to the international legal practice that comprises Hogan Lovells International LLP, Hogan Lovells US LLP and their affiliated businesses, each of which is a separate legal entity. Attorney advertising. Prior results do not guarantee a similar outcome.